Xuzhou, China

Mingxi Tang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mingxi Tang

Introduction

Mingxi Tang is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the area of pain management. His work focuses on developing methods to enhance the efficacy of morphine, a widely used analgesic.

Latest Patents

Mingxi Tang holds a patent for a pharmaceutical composition and method for relieving or eliminating morphine-induced analgesic tolerance. This innovative composition includes a therapeutically effective amount of a short peptide and morphine as active ingredients, along with a pharmaceutically acceptable carrier. The short peptide consists of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically acceptable salt thereof. The method involves administering the short peptide and morphine to a subject simultaneously, or injecting the short peptide followed by morphine administration.

Career Highlights

Mingxi Tang is affiliated with Xuzhou Medical University, where he conducts research and develops his innovative pharmaceutical solutions. His work has the potential to significantly improve pain management strategies for patients suffering from chronic pain conditions.

Collaborations

Mingxi Tang collaborates with esteemed colleagues, including Qiongyao Tang and Zhe Zhang, to further advance research in his field. Their combined expertise contributes to the development of effective pharmaceutical compositions.

Conclusion

Mingxi Tang's contributions to pharmaceutical innovation, particularly in addressing morphine-induced analgesic tolerance, highlight his role as a significant inventor in the medical field. His work promises to enhance pain management therapies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…